The World Congress Summit on Real World Data Strategies 2014

Key Topics

• Develop Better Treatment Pathways and Optimize Efficacy in Comparative Effectiveness Research
• The Future of Regulations—Understand the Sentinel Initiative and the Next Steps for the FDA
• Create Interoperability Between Electronic Data Sources to Enhance Data for Demonstrating Improved Outcomes
• Maximize Value of Registry Data for Improved Discovery and Innovation
• The Intersection of Pharmaceutical Manufacturers and ACOs—Leveraging Data for New Payment Models
• Balancing Data Expectations of Regulators and Payers for an Efficient Post-Marketing Strategy
• Enhance Large Scale Clinical Data Association Studies with Privacy Protections
• Data Linkages: How Real World Data can be Maximized to Support Development and Post Marketing Research Programs
• Case Study: Patients Like Me—The Evolution of a Patient Powered Research Network
• Prepare for the Future of Big Data – How to Create Richer Data Sources Now
• Case Study: Disease Registries—Real World Study Design

Who should Attend

Biotech and pharmaceutical VPs, SVPs and Directors of:

• Post-Approval/Post-Marketing
• Phase IV/Late Phase
• Outcomes Research
• Health Economics
• Patient Registries
• Real World Data/Evidence
• Medical Affairs
• Disease Registries
• Clinical Operations
• Clinical Affairs
• Surveillance/Safety
• Scientific Affairs
• Pharmacovigilance
• Regulatory Affairs
• Risk Management